Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GROM NASDAQ:ICCT NASDAQ:KBNT NASDAQ:KLDO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGROMGrom Social Enterprises$0.00$0.00$0.00▼$0.31$4K1.611,888 shs1 shsICCTiCoreConnect$0.00+110.0%$0.07$0.00▼$14.37$10K-1.547.39 million shs17,735 shsKBNTKubient$0.00$0.00$0.00▼$0.00$1K1.053,276 shs330 shsKLDOKaleido Biosciences$0.00$0.00▼$0.07$6.39M-0.0611,132 shsN/A(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGROMGrom Social Enterprises0.00%0.00%0.00%-55.56%-99.33%ICCTiCoreConnect0.00%+400.00%-98.75%-99.78%-99.99%KBNTKubient0.00%0.00%0.00%0.00%-50.00%KLDOKaleido Biosciences0.00%0.00%-99.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGROMGrom Social Enterprises$0.00$0.00$0.00▼$0.31$4K1.611,888 shs1 shsICCTiCoreConnect$0.00+110.0%$0.07$0.00▼$14.37$10K-1.547.39 million shs17,735 shsKBNTKubient$0.00$0.00$0.00▼$0.00$1K1.053,276 shs330 shsKLDOKaleido Biosciences$0.00$0.00▼$0.07$6.39M-0.0611,132 shsN/A(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGROMGrom Social Enterprises0.00%0.00%0.00%-55.56%-99.33%ICCTiCoreConnect0.00%+400.00%-98.75%-99.78%-99.99%KBNTKubient0.00%0.00%0.00%0.00%-50.00%KLDOKaleido Biosciences0.00%0.00%-99.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGROMGrom Social Enterprises 0.00N/AN/AN/AICCTiCoreConnect 0.00N/AN/AN/AKBNTKubient 0.00N/AN/AN/AKLDOKaleido Biosciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGROMGrom Social Enterprises$3.72M0.00N/AN/A$6.25 per share0.00ICCTiCoreConnect$11.05M0.00N/AN/A$9.93 per share0.00KBNTKubient$1.17M0.00N/AN/AN/A∞KLDOKaleido Biosciences$1.10M0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGROMGrom Social Enterprises-$12.53M-$11.67N/A∞N/AN/AN/AN/AN/AICCTiCoreConnect-$15.55M-$63.20N/A∞N/A-263.12%-1,451.73%-171.32%N/AKBNTKubient-$13.62MN/A0.00∞N/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/A-$2.24N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGROMGrom Social EnterprisesN/AN/AN/AN/AN/AICCTiCoreConnectN/AN/AN/AN/AN/AKBNTKubientN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGROMGrom Social EnterprisesN/AN/AN/AICCTiCoreConnect7.930.110.11KBNTKubientN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGROMGrom Social Enterprises15.94%ICCTiCoreConnect13.42%KBNTKubient13.91%KLDOKaleido Biosciences81.56%Insider OwnershipCompanyInsider OwnershipGROMGrom Social Enterprises0.01%ICCTiCoreConnect59.42%KBNTKubient22.33%KLDOKaleido Biosciences9.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGROMGrom Social Enterprises4509.02 million9.02 millionNot OptionableICCTiCoreConnect414.88 million841,000Not OptionableKBNTKubient4014.51 million11.44 millionOptionableKLDOKaleido Biosciences8042.62 million38.79 millionNot OptionableKBNT, GROM, ICCT, and KLDO HeadlinesRecent News About These CompaniesViCentra Raises $85M to Scale Manufacturing and Accelerate Market Penetration of Kaleido Insulin Patch PumpSeptember 3, 2025 | pharmiweb.comPViCentra prepares for big commercial push with its Kaleido automated insulin patch pumpSeptember 3, 2025 | drugdeliverybusiness.comDKaleido Life Introduces the Third Way to Fund Your Future: Cash. Credit. Kaleido.May 19, 2025 | gritdaily.comGKaleido Biosciences Inc (KLDO)April 10, 2025 | uk.investing.comCelebration As NSW’s First LGBTQIA+ Dedicated Health Service Kaleido Opens Its DoorsApril 9, 2025 | starobserver.com.auSKaleido Intelligence: Transport & Logistics Cellular Data to Surpass 2 Exabytes by 2030April 3, 2025 | thefastmode.comTKaleido, Mobilesquared Announce Merger to Revolutionize Mobile Market IntelligenceJanuary 19, 2025 | thefastmode.comTSyniverse Named Leader in Mobile Roaming by Kaleido Intelligence for Fourth Straight YearDecember 11, 2024 | finance.yahoo.comBICS, Cellusys, Comfone, Mobileum, Syniverse, Telefónica Global Solutions & TOMIA MACH Named Champion Roaming Vendors by Kaleido IntelligenceNovember 25, 2024 | markets.businessinsider.comNew PocketBook Color Note With 10.3-inch E Ink Kaleido 3 Mobius Display LaunchedNovember 1, 2024 | goodereader.comGViCentra wins CE mark for Kaleido insulin pumpOctober 21, 2024 | drugdeliverybusiness.comDKaleido Biosciences (OTC:KLDO) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comKaleido announces the appointment of RBC Investor Services as the new custodian of its scholarship plansOctober 1, 2024 | ca.finance.yahoo.comNew Readmoo mooInk Nana e-Reader With 7-inch Kaleido 3 Display LaunchedSeptember 29, 2024 | goodereader.comGiReader Smart 5C e-Note With 10.3-inch Kaleido 3 to Launch on Sept. 23September 14, 2024 | goodereader.comGOnyx Boox T10C e-Note With Kaleido 3 Display LaunchedSeptember 7, 2024 | goodereader.comGMoaan Pantone 7 e-Reader with Kaleido 3 E-Paper Display Now AvailableAugust 19, 2024 | goodereader.comGKaleidoscope Digital Media Systems, DBA of Kaleidoscope Venture Capital Inc., Announces the Creation of Kaleidoscope Internet...August 17, 2024 | br.advfn.comLoFone, the Latest Anti-Smartphone to Feature E Ink Kaleido 3 DisplayAugust 11, 2024 | goodereader.comGPocketBook Verse Pro Color With 6-inch Kaleido 3 Display LaunchedJuly 30, 2024 | goodereader.comGNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKBNT, GROM, ICCT, and KLDO Company DescriptionsGrom Social Enterprises NASDAQ:GROM$0.0004 0.00 (0.00%) As of 09/5/2025Grom Social Enterprises, Inc., through its subsidiaries, operates as a media, technology, and entertainment company in the United States and Philippines. It operates through three segments: Animation, Original Content, and Social and Technology. The company operates a social media network for children under the age of 13 years. It also produces animated films and televisions series; and provides web filtering services to schools and government agencies, as well as acquires, develops, and builds commercial potential of kids and family entertainment properties and associated business opportunities. Grom Social Enterprises, Inc. was founded in 2012 and is headquartered in Boca Raton, Florida.iCoreConnect NASDAQ:ICCT$0.0021 +0.00 (+110.00%) As of 02:49 PM EasterniCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.Kubient NASDAQ:KBNT$0.0001 0.00 (0.00%) As of 12:50 PM EasternKubient, Inc. develops a cloud-based software platform for digital advertising industry. It develops Audience Marketplace, a platform for real-time trading of digital, programmatic advertising. The company's platform allows advertisers and publishers the ability to use machine learning during programmatic advertising inventory auction. The company was incorporated in 2017 and is based in New York, New York.Kaleido Biosciences NASDAQ:KLDOKaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insiders Sell These High-Quality Stocks: Why Investors Shouldn’t 2 Small-Cap Dividend-Paying Retailers to Buy and Hold for 2026 What August Labor Data Means for the S&P 500 in September MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Eyes on the Sky: AST SpaceMobile Prepares for Commercial Launch Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
